{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:42:57Z","timestamp":1768340577651,"version":"3.49.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Medical literature on the prevalence of genetic liver disease is lacking. In this study, we investigated the in-hospital healthcare and economic burden from genetic causes of non-alcoholic chronic liver disease (NACLD) and non-alcoholic liver cirrhosis (NALC) in the USA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were abstracted from the National Inpatient Sample database between 2002 and 2014 using ICD9 codes for patients discharged with NACLD and NALC secondary to genetic diseases including alpha-1 antitrypsin deficiency (A1ATd), cystic fibrosis (CF), Wilson disease (WD), hereditary hemochromatosis (HHC), glycogen storage disease, and disorders of aromatic amino-acid metabolism (DAAAM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Throughout the study period, there were 19,332 discharges for NACLD associated with the six genetic diseases including 14,368 for NALC. There were $1.09 billion in hospital charges, 790 in-hospital deaths, and 955 liver transplants performed. Overall, A1ATd was associated with 8,983 (62.52%) hospitalizations for NALC followed by WD, CF, and HHC. The highest in-hospital mortality was seen with HHC. The greatest frequency of liver transplants was seen with DAAAM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The number of hospitalizations for genetic liver diseases continues to increase. With increased funding and directed research efforts, we can aim to improve medical treatments and the quality of life for patients at risk for liver deterioration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gastro\/goaa091","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T02:44:58Z","timestamp":1607395498000},"page":"38-48","source":"Crossref","is-referenced-by-count":6,"title":["National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2137-037X","authenticated-orcid":false,"given":"Eric M","family":"Sieloff","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4766-909X","authenticated-orcid":false,"given":"Brian","family":"Rutledge","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology, Wayne State University School of Medicine, Detroit, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuyler","family":"Huffman","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Melgar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Adolescent and Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2021031615392752100_goaa091-B1","year":"2018"},{"key":"2021031615392752100_goaa091-B2","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"2021031615392752100_goaa091-B3","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000062","article-title":"Increasing economic burden in hospitalized patients with cirrhosis: analysis of a national database","volume":"10","author":"Desai","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"2021031615392752100_goaa091-B4","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2021031615392752100_goaa091-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/713754","article-title":"Genetic diseases that predispose to early liver cirrhosis","volume":"2014","author":"Scorza","year":"2014","journal-title":"Int J Hepatol"},{"key":"2021031615392752100_goaa091-B6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cld.2007.04.002","article-title":"Liver transplantation for metabolic liver diseases","volume":"11","author":"Zhang","year":"2007","journal-title":"Clin Liver Dis"},{"key":"2021031615392752100_goaa091-B7"},{"key":"2021031615392752100_goaa091-B8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1378\/chest.128.3.1179","article-title":"Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003","volume":"128","author":"Campos","year":"2005","journal-title":"Chest"},{"key":"2021031615392752100_goaa091-B9","doi-asserted-by":"crossref","first-page":"1800360","DOI":"10.1183\/13993003.00360-2018","article-title":"Trends of testing for and diagnosis of \u03b1(1)-antitrypsin deficiency in the UK: more\u00a0testing is needed","volume":"52","author":"Soriano","year":"2018","journal-title":"Eur Respir J"},{"key":"2021031615392752100_goaa091-B10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-510X(00)00399-3","article-title":"A novel deletion mutation within the carboxyl terminus of the copper-transporting ATPase gene causes Wilson disease","volume":"179","author":"Majumdar","year":"2000","journal-title":"J Neurol Sci"},{"key":"2021031615392752100_goaa091-B11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8278(00)00028-3","article-title":"The Wilson's disease gene and phenotypic diversity","volume":"34","author":"Riordan","year":"2001","journal-title":"J Hepatol"},{"key":"2021031615392752100_goaa091-B12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/14737159.2.1.49","article-title":"Molecular testing for hereditary hemochromatosis","volume":"2","author":"Liang","year":"2002","journal-title":"Expert Rev Mol Diagn"},{"key":"2021031615392752100_goaa091-B13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/BF01296661","article-title":"Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency","volume":"32","author":"Rakela","year":"1987","journal-title":"Digest Dis Sci"},{"key":"2021031615392752100_goaa091-B14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1542-3565(05)00082-0","article-title":"Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency","volume":"3","author":"Bowlus","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021031615392752100_goaa091-B15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"2021031615392752100_goaa091-B16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-127-2-199707150-00002","article-title":"Clinical features of genetic hemochromatosis in women compared with men","volume":"127","author":"Moirand","year":"1997","journal-title":"Ann Intern Med"},{"key":"2021031615392752100_goaa091-B17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2011.08.028","article-title":"Gender differences in Wilson's disease","volume":"312","author":"Litwin","year":"2012","journal-title":"J Neurol Sci"},{"key":"2021031615392752100_goaa091-B18","first-page":"45","article-title":"Glycogen storage diseases: diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Transl Sci Rare Dis"},{"key":"2021031615392752100_goaa091-B19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: a review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr Dev Pathol"},{"key":"2021031615392752100_goaa091-B20","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1572-0241.2008.01955.x","article-title":"Liver disease in alpha 1-antitrypsin deficiency: a review","volume":"103","author":"Fairbanks","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2021031615392752100_goaa091-B21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.89.3.370","article-title":"Alpha 1-antitrypsin pi-types in 965 COPD patients","volume":"89","author":"Lieberman","year":"1986","journal-title":"Chest"},{"key":"2021031615392752100_goaa091-B22","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.14309\/ajg.0000000000000700","article-title":"How I approach patients with elevated serum ferritin","volume":"115","author":"Palmer","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2021031615392752100_goaa091-B23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/modpathol.2010.42","article-title":"HFE mutations in alpha-1-antitrypsin deficiency: an examination of cirrhotic explants","volume":"23","author":"Lam","year":"2010","journal-title":"Mod Pathol"},{"key":"2021031615392752100_goaa091-B24","year":"2013"},{"key":"2021031615392752100_goaa091-B25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"2021031615392752100_goaa091-B26","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/gim.2017.101","article-title":"Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations","volume":"19","author":"Chinsky","year":"2017","journal-title":"Genet Med"},{"key":"2021031615392752100_goaa091-B27","first-page":"311","article-title":"Tyrosinemia: the Quebec experience","volume":"19","author":"Paradis","year":"1996","journal-title":"Clin Invest Med"},{"key":"2021031615392752100_goaa091-B28","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives","volume":"13","author":"Ozen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"2021031615392752100_goaa091-B29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"key":"2021031615392752100_goaa091-B30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.30945","article-title":"Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family","volume":"139A","author":"L'Hermine-Coulomb","year":"2005","journal-title":"Am J Med Genet A"},{"key":"2021031615392752100_goaa091-B31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"key":"2021031615392752100_goaa091-B32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet Med"},{"key":"2021031615392752100_goaa091-B33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2021031615392752100_goaa091-B34","first-page":"69","article-title":"Liver disease in cystic fibrosis","volume":"15","author":"Leeuwen","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"2021031615392752100_goaa091-B35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis","volume":"66","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child"},{"key":"2021031615392752100_goaa091-B36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.1840160215","article-title":"Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis","volume":"16","author":"Lindblad","year":"1992","journal-title":"Hepatology"},{"key":"2021031615392752100_goaa091-B37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease","volume":"27","author":"Lindblad","year":"1998","journal-title":"Hepatology"},{"key":"2021031615392752100_goaa091-B38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transpl"},{"key":"2021031615392752100_goaa091-B39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1155\/2006\/428048","article-title":"Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis","volume":"20","author":"Beaton","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"2021031615392752100_goaa091-B40","first-page":"853","article-title":"Recognition and management of hereditary hemochromatosis","volume":"65","author":"Brandhagen","year":"2002","journal-title":"Am Fam Physician"},{"key":"2021031615392752100_goaa091-B41","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"key":"2021031615392752100_goaa091-B42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/lt.23449","article-title":"Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis","volume":"18","author":"Ali","year":"2012","journal-title":"Liver Transpl"},{"key":"2021031615392752100_goaa091-B43","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"2021031615392752100_goaa091-B44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11605-007-0103-5","article-title":"Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States","volume":"11","author":"Scarborough","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"2021031615392752100_goaa091-B45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1399-3062.2012.00761.x","article-title":"Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database","volume":"14","author":"Pant","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"2021031615392752100_goaa091-B46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archsurg.2010.17","article-title":"Early clinical and economic outcomes of patients undergoing living donor nephrectomy in the United States","volume":"145","author":"Friedman","year":"2010","journal-title":"Arch Surg"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/9\/1\/38\/36618331\/goaa091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/9\/1\/38\/36618331\/goaa091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T20:37:03Z","timestamp":1615927023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/9\/1\/38\/6101108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,3,16]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/goaa091","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2021,1,1]]}}}